サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1298887

特殊ジェネリック医薬品市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
特殊ジェネリック医薬品市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の特殊ジェネリック医薬品市場規模は2022年に674億米ドルに達しました。今後、IMARC Groupは2023年から2028年にかけて10.8%の成長率（CAGR）を示し、2028年には1,254億米ドルに達すると予測しています。

特殊ジェネリック医薬品は、特許が切れたスペシャリティ医薬品のジェネリック医薬品です。これらの医薬品は、がん、自己免疫疾患、てんかん、HIV、肝炎、多発性硬化症、関節リウマチなどの慢性疾患や複雑な健康状態の治療に使用されます。特殊ジェネリック医薬品は、高価な開発・販売コストを必要としないため、ブランド品と比較して費用対効果が高いです。

従来のジェネリック医薬品に比べ、特殊ジェネリック医薬品市場は、複雑な製造要件、高い資本コスト、患者数が少ないため相対的に販売数量が少なく、プレーヤーが集中しています。その結果、先発医薬品に比べて薬価の引き下げ幅が小さくなり、従来のジェネリック医薬品に比べて利益率が高くなります。特殊なジェネリック医薬品は特別な取り扱い、投与、モニタリングが必要であり、一般的に注文には事前承認が必要となります。世界の特殊ジェネリック医薬品市場は現在、高齢化人口の増加、多くのブランド特殊医薬品の特許切れ、がん、多発性硬化症、ヘルスケアなど生命を脅かす様々な疾患の有病率の増加、医療提供者のコスト抑制策、新興市場の成長など、いくつかの要因によって牽引されています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 特殊ジェネリック医薬品の世界市場イントロダクション

第5章 特殊ジェネリック医薬品はなぜ有利なのか？

第6章 特殊ジェネリック医薬品の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：投与経路別
  • 市場内訳：適応症別
  • 市場内訳：流通チャネル別
  • 市場内訳：地域別
  • 市場予測
  • SWOT分析
    • 概要
    • 強み
    • 弱み
    • 機会
    • 脅威
  • バリューチェーン分析
  • ポーターのファイブフォース分析
    • 概要
    • 買い手の交渉力
    • 供給企業の交渉力
    • 競合の程度
    • 新規参入業者の脅威
    • 代替品の脅威
  • 市場促進要因と成功要因

第7章 市場内訳：投与経路別

  • 注射剤
    • 市場動向
    • 市場予測
  • 経口剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：適応症別

  • がん領域
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • 小売薬局
    • 市場動向
    • 市場予測
  • 専門薬局
    • 市場動向
    • 市場予測
  • 病院薬局
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 市場概要
    • 市場実績
    • 市場内訳：国別
      • 米国
        • 市場動向
        • 市場予測
      • カナダ
        • 市場動向
        • 市場予測
    • 市場予測
  • 欧州
    • 市場概要
    • 市場実績
    • 市場内訳：国別
      • イタリア
        • 市場動向
        • 市場予測
      • ドイツ
        • 市場動向
        • 市場予測
      • フランス
        • 市場動向
        • 市場予測
      • 英国
        • 市場動向
        • 市場予測
      • スペイン
        • 市場動向
        • 市場予測
    • 市場予測
  • アジア太平洋
    • 市場概要
    • 市場実績
    • 市場内訳：国別
      • 日本
        • 市場動向
        • 市場予測
      • 中国
        • 市場動向
        • 市場予測
      • インド
        • 市場動向
        • 市場予測
      • 韓国
        • 市場動向
        • 市場予測
    • 市場予測
  • ラテンアメリカ
    • 市場概要
    • 市場実績
    • 市場内訳：国別
      • ブラジル
        • 市場動向
        • 市場予測
      • メキシコ
        • 市場動向
        • 市場予測
    • 市場予測
  • 中東・アフリカ
    • 市場概要
    • 市場実績
    • 市場予測

第11章 競合情勢

  • 市場構造
  • 主要プレーヤー
  • 主要プレーヤーのプロファイル
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
図表

List of Figures

  • Figure 1: Global: Specialty Generics Market: Major Drivers and Challenges
  • Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
  • Figure 4: Global: Specialty Generics Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 9: Global: Specialty Generics Industry: Value Chain Analysis
  • Figure 10: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2017 & 2022
  • Figure 12: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 13: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2017 & 2022
  • Figure 14: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 15: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2017 & 2022
  • Figure 16: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 17: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2017 & 2022
  • Figure 18: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 19: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2017 & 2022
  • Figure 20: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 21: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2017 & 2022
  • Figure 22: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 23: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2017 & 2022
  • Figure 24: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 25: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2017 & 2022
  • Figure 26: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2023-2028
  • Figure 27: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2017 & 2022
  • Figure 28: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2023-2028
  • Figure 29: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2017 & 2022
  • Figure 30: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2023-2028
  • Figure 31: North America: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Italy: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Germany: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: France: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Spain: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Specialty Generics Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2023-2028
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2023-2028
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2023-2028
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2023-2028
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players
目次
Product Code: SR112023A1219

The global specialty generics market size reached US$ 67.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 125.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.8% during 2023-2028.

Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global specialty generics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

North America

United States

Canada

Europe

Italy

Germany

Spain

United Kingdom

France

Asia-Pacific

China

India

Japan

South Korea

Latin America

Brazil

Mexico

Middle East and Africa

Breakup by Route of Administration:

Injectables

Oral

Others

Breakup by Indication:

Oncology

Autoimmune Diseases

Infectious Diseases

Others

Breakup by Distribution channel:

Retail Pharmacies

Specialty Pharmacies

Hospital Pharmacies

Competitive Landscape:

The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Key Questions Answered in This Report

1. What is the size of the global specialty generics market?

2. What are the key factors driving the global specialty generics market?

3. What has been the impact of COVID-19 on the global specialty generics market?

4. What is the breakup of the global specialty generics market based on the route of administration?

5. What is the breakup of the global specialty generics market based on the indication?

6. What is the breakup of the global specialty generics market based on the distribution channel?

7. What are the key regions in the global specialty generics market?

8. Who are the key players/companies in the global specialty generics market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3   Executive Summary

4   Global Specialty Generics Market: Introduction

5   Why are Specialty Generics So Lucrative?

6   Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Impact of COVID-19
  • 6.4 Market Breakup by Route of Administration
  • 6.5 Market Breakup by Indication
  • 6.6 Market Breakup by Distribution Channel
  • 6.7 Market Breakup by Region
  • 6.8 Market Forecast
  • 6.9 SWOT Analysis
    • 6.9.1 Overview
    • 6.9.2 Strengths
    • 6.9.3 Weaknesses
    • 6.9.4 Opportunities
    • 6.9.5 Threats
  • 6.10 Value Chain Analysis
  • 6.11 Porters Five Forces Analysis
    • 6.11.1 Overview
    • 6.11.2 Bargaining Power of Buyers
    • 6.11.3 Bargaining Power of Suppliers
    • 6.11.4 Degree of Competition
    • 6.11.5 Threat of New Entrants
    • 6.11.6 Threat of Substitutes
  • 6.12 Key Market Drivers and Success Factors

7   Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9   Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10  Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
      • 10.1.3.1 United States
        • 10.1.3.1.1 Market Trends
        • 10.1.3.1.2 Market Forecast
      • 10.1.3.2 Canada
        • 10.1.3.2.1 Market Trends
        • 10.1.3.2.2 Market Forecast
    • 10.1.4 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
      • 10.2.3.1 Italy
        • 10.2.3.1.1 Market Trends
        • 10.2.3.1.2 Market Forecast
      • 10.2.3.2 Germany
        • 10.2.3.2.1 Market Trends
        • 10.2.3.2.2 Market Forecast
      • 10.2.3.3 France
        • 10.2.3.3.1 Market Trends
        • 10.2.3.3.2 Market Forecast
      • 10.2.3.4 United Kingdom
        • 10.2.3.4.1 Market Trends
        • 10.2.3.4.2 Market Forecast
      • 10.2.3.5 Spain
        • 10.2.3.5.1 Market Trends
        • 10.2.3.5.2 Market Forecast
    • 10.2.4 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
      • 10.3.3.1 Japan
        • 10.3.3.1.1 Market Trends
        • 10.3.3.1.2 Market Forecast
      • 10.3.3.2 China
        • 10.3.3.2.1 Market Trends
        • 10.3.3.2.2 Market Forecast
      • 10.3.3.3 India
        • 10.3.3.3.1 Market Trends
        • 10.3.3.3.2 Market Forecast
      • 10.3.3.4 South Korea
        • 10.3.3.4.1 Market Trends
        • 10.3.3.4.2 Market Forecast
    • 10.3.4 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
      • 10.4.3.1 Brazil
        • 10.4.3.1.1 Market Trends
        • 10.4.3.1.2 Market Forecast
      • 10.4.3.2 Mexico
        • 10.4.3.2.1 Market Trends
        • 10.4.3.2.2 Market Forecast
    • 10.4.4 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11  Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc.